A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables

Can We Predict the High-Risk Patient?

(2014) Jose-Manuel Benitez et al.   DIGESTIVE DISEASES

Hemoglobin and Hematocrit Levels in the Prediction of Complicated Crohn's Disease Behavior – A Cohort Study

(2014) Florian Rieder et al.   PLoS One

Predicting complicated Crohn's disease and surgery: phenotypes, genetics, serology and psychological characteristics of a population-based cohort

(2013) J. D. Ryan et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Risk Matrix for Prediction of Advanced Disease in a Population-based Study of Patients with Crohnʼs Disease (the IBSEN Study)

(2013) Inger C. Solberg et al.   INFLAMMATORY BOWEL DISEASES

Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease

(2012) Luke Jostins et al.   NATURE

The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn’s disease

(2011) A. Eser et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Shared decision making in inflammatory bowel disease: helping patients understand the tradeoffs between treatment options

(2011) Corey A Siegel   GUT

Prediction of disease complication occurrence in Crohn's disease using phenotype and genotype parameters at diagnosis

(2011) Yoav Mazor et al.   Journal of Crohns & Colitis

Real-time tool to display the predicted disease course and treatment response for children with Crohnʼs disease

(2010) Corey A. Siegel et al.   INFLAMMATORY BOWEL DISEASES

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum anti-glycan antibodies predict complicated Crohnʼs disease behavior

(2009) Florian Rieder et al.   INFLAMMATORY BOWEL DISEASES

Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children

(2008) Marla C. Dubinsky et al.   Clinical Gastroenterology and Hepatology

Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort

(2008) R K Weersma et al.   GUT

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET